• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床试验设计的未来:从硬性终点向基于价值的终点的转变。

The Future of Clinical Trial Design: The Transition from Hard Endpoints to Value-Based Endpoints.

作者信息

Kruizinga Matthijs D, Stuurman Frederik E, Groeneveld Geert J, Cohen Adam F

机构信息

Centre for Human Drug Research, Leiden, The Netherlands.

Juliana Children's Hospital, HAGA Teaching Hospital, The Hague, The Netherlands.

出版信息

Handb Exp Pharmacol. 2019;260:371-397. doi: 10.1007/164_2019_302.

DOI:10.1007/164_2019_302
PMID:31707472
Abstract

Clinical trials have been conducted since 500 BC. Currently, the methodological gold standard is the randomized controlled clinical trial, introduced by Austin Bradford Hill. This standard has produced enormous amounts of high-quality evidence, resulting in evidence-based clinical guidelines for physicians. However, the current trial paradigm needs to evolve because of the ongoing decrease of the incidence of hard endpoints and spiraling trial costs. While new trial designs, such as adaptive clinical trials, may lead to an increase in efficiency and decrease in costs, we propose a shift towards value-based trial design: a paradigm that mirrors value-based thinking in business and health care. Value-based clinical trials will use technology to focus more on symptoms and endpoints that patients care about, will incorporate fewer research centers, and will measure a state or consequence of disease at home or at work. Furthermore, they will measure the subjective experience of subjects in relation to other objective measurements. Ideally, the endpoints are suitable for individual assessment of the effect of an intervention. The value-based clinical trial of the future will have a low burden for participants, allowing for the inclusion of neglected populations such as children and the elderly, will be data-rich due to a high frequency of measurements, and can be conducted with technology that is already available.

摘要

自公元前500年起就开始进行临床试验。目前,方法学的金标准是由奥斯汀·布拉德福德·希尔引入的随机对照临床试验。这一标准产生了大量高质量证据,从而形成了针对医生的循证临床指南。然而,由于硬终点事件发生率持续下降以及试验成本不断攀升,当前的试验模式需要改进。虽然新的试验设计,如适应性临床试验,可能会提高效率并降低成本,但我们建议转向基于价值的试验设计:一种反映商业和医疗保健领域基于价值思维的模式。基于价值的临床试验将利用技术,更多地关注患者关心的症状和终点,减少研究中心的数量,并在家庭或工作场所测量疾病的状态或后果。此外,它们将在与其他客观测量相关的情况下测量受试者的主观体验。理想情况下,这些终点适用于对干预效果的个体评估。未来基于价值的临床试验对参与者的负担较小,能够纳入儿童和老年人等被忽视的人群,由于测量频率高而数据丰富,并且可以使用现有的技术进行。

相似文献

1
The Future of Clinical Trial Design: The Transition from Hard Endpoints to Value-Based Endpoints.临床试验设计的未来:从硬性终点向基于价值的终点的转变。
Handb Exp Pharmacol. 2019;260:371-397. doi: 10.1007/164_2019_302.
2
Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.急性缺血性脑卒中动脉内脑溶栓的试验设计与报告标准。
Stroke. 2003 Aug;34(8):e109-37. doi: 10.1161/01.STR.0000082721.62796.09. Epub 2003 Jul 17.
3
Outcome measurement in female sexual dysfunction clinical trials: review and recommendations.女性性功能障碍临床试验中的结果测量:综述与建议。
J Sex Marital Ther. 2005 Mar-Apr;31(2):153-66. doi: 10.1080/00926230590909989.
4
5
Improving outcome reporting in clinical trial reports and protocols: study protocol for the Instrument for reporting Planned Endpoints in Clinical Trials (InsPECT).改善临床试验报告和方案中的结果报告:临床试验计划终点报告工具(InsPECT)的研究方案。
Trials. 2019 Mar 6;20(1):161. doi: 10.1186/s13063-019-3248-0.
6
Reducing unnecessary measurements in clinical trials with multiple primary endpoints.减少具有多个主要终点的临床试验中的不必要测量。
J Biopharm Stat. 2016;26(4):631-43. doi: 10.1080/10543406.2015.1052497. Epub 2015 Jun 22.
7
Outcomes and endpoints in trials of cancer treatment: the past, present, and future.癌症治疗试验中的结局和终点:过去、现在和未来。
Lancet Oncol. 2015 Jan;16(1):e32-42. doi: 10.1016/S1470-2045(14)70375-4. Epub 2014 Dec 29.
8
American Society of Clinical Oncology policy statement: oversight of clinical research.美国临床肿瘤学会政策声明:临床研究监督
J Clin Oncol. 2003 Jun 15;21(12):2377-86. doi: 10.1200/JCO.2003.04.026. Epub 2003 Apr 29.
9
Prostate cancer chemoprevention: Strategies for designing efficient clinical trials.前列腺癌化学预防:设计有效临床试验的策略
Urology. 2001 Apr;57(4 Suppl 1):224-9. doi: 10.1016/s0090-4295(00)00981-x.
10
Development of Novel, Value-Based, Digital Endpoints for Clinical Trials: A Structured Approach Toward Fit-for-Purpose Validation.开发新型、基于价值的临床试验数字化终点:一种有针对性的适合用途验证方法。
Pharmacol Rev. 2020 Oct;72(4):899-909. doi: 10.1124/pr.120.000028.

引用本文的文献

1
Evolution of reported patient and public involvement over time in randomised controlled trials in major medical journals and in their protocols: meta-epidemiological evaluation.主要医学期刊及其方案中随机对照试验中报告的患者和公众参与随时间的演变:元流行病学评估
BMJ. 2025 Apr 10;389:e082697. doi: 10.1136/bmj-2024-082697.
2
Sacubitril/Valsartan vs ACE Inhibitors or ARBs: A Systematic Review and Meta-Analysis of Randomized Trials.沙库巴曲缬沙坦与血管紧张素转换酶抑制剂或血管紧张素Ⅱ受体拮抗剂对比:随机试验的系统评价与荟萃分析
JACC Adv. 2025 Mar;4(3):101598. doi: 10.1016/j.jacadv.2025.101598. Epub 2025 Feb 18.
3
Unmet medical needs definition and incentives: stakeholders perspectives on the reform of the EU pharmaceutical legislation.
未满足的医疗需求定义与激励措施:利益相关者对欧盟药品立法改革的看法
Front Med (Lausanne). 2025 Jan 7;11:1506243. doi: 10.3389/fmed.2024.1506243. eCollection 2024.
4
Anticancer potential of phytochemicals derived from mangrove plants: Comprehensive mechanistic insights.源自红树林植物的植物化学物质的抗癌潜力:全面的机制见解。
Food Sci Nutr. 2024 Jul 10;12(9):6174-6205. doi: 10.1002/fsn3.4318. eCollection 2024 Sep.
5
Development and technical validation of a smartphone-based pediatric cough detection algorithm.基于智能手机的小儿咳嗽检测算法的开发和技术验证。
Pediatr Pulmonol. 2022 Mar;57(3):761-767. doi: 10.1002/ppul.25801. Epub 2022 Jan 11.
6
Accelerating vaccine trial conduct in a pandemic with a hot spot-based inclusion strategy using trial and epidemic simulation.利用基于热点的纳入策略,通过试验和疫情模拟,加速大流行期间的疫苗试验进行。
Clin Transl Sci. 2021 Nov;14(6):2391-2398. doi: 10.1111/cts.13104. Epub 2021 Jul 14.
7
Stakeholder Perspectives on Barriers and Facilitators for the Adoption of Virtual Clinical Trials: Qualitative Study.利益相关者对采用虚拟临床试验的障碍和促进因素的观点:定性研究。
J Med Internet Res. 2021 Jul 6;23(7):e26813. doi: 10.2196/26813.
8
Postdischarge Recovery after Acute Pediatric Lung Disease Can Be Quantified with Digital Biomarkers.急性儿科肺部疾病出院后的恢复情况可以通过数字生物标志物进行量化。
Respiration. 2021;100(10):979-988. doi: 10.1159/000516328. Epub 2021 May 18.
9
Towards remote monitoring in pediatric care and clinical trials-Tolerability, repeatability and reference values of candidate digital endpoints derived from physical activity, heart rate and sleep in healthy children.迈向儿科护理和临床试验的远程监测——健康儿童的身体活动、心率和睡眠衍生的候选数字终点的耐受性、可重复性和参考值。
PLoS One. 2021 Jan 7;16(1):e0244877. doi: 10.1371/journal.pone.0244877. eCollection 2021.
10
Technical validity and usability of a novel smartphone-connected spirometry device for pediatric patients with asthma and cystic fibrosis.一种新型智能手机连接式肺功能仪在哮喘和囊性纤维化患儿中的技术有效性和可用性研究。
Pediatr Pulmonol. 2020 Sep;55(9):2463-2470. doi: 10.1002/ppul.24932. Epub 2020 Jul 8.